Published in Cancer Epidemiol Biomarkers Prev on February 01, 1997
Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer (2012) 1.33
Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci U S A (1999) 1.23
Genetic susceptibility to lung cancer--light at the end of the tunnel? Carcinogenesis (2013) 1.00
Review of studies on metabolic genes and cancer in populations of African descent. Genet Med (2010) 0.96
Biomarkers of leukemia risk: benzene as a model. Environ Health Perspect (1998) 0.91
Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease. Cancer Res (2008) 0.90
The NQO1 allelic frequency in hindu population of central India varies from that of other Asian populations. Indian J Hum Genet (2010) 0.85
Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One (2012) 0.82
Tungsten-induced carcinogenesis in human bronchial epithelial cells. Toxicol Appl Pharmacol (2015) 0.79
CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population. Int J Mol Epidemiol Genet (2013) 0.78
Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health (2013) 0.75
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob Agents Chemother (1993) 5.08
HIV in prisons. BMJ (1988) 3.81
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 3.52
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet (1993) 3.36
Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst (1999) 2.88
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst (1999) 2.68
A study of the "crossover population": aged persons entitled to both Medicare and Medicaid. Health Care Financ Rev (1983) 2.53
Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst (2000) 2.33
Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes. Antimicrob Agents Chemother (1992) 2.17
Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions. Br J Vener Dis (1982) 2.04
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
The dually entitled elderly Medicare and Medicaid population living in the community. Health Care Financ Rev (1984) 1.99
Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.98
Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis (2000) 1.97
p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res (2001) 1.88
Screening for treponemal infection by a new enzyme immunoassay. Genitourin Med (1989) 1.88
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst (1998) 1.81
Urinary 1-hydroxypyrene and polycyclic aromatic hydrocarbon exposure among asphalt paving workers. Ann Occup Hyg (2004) 1.78
Sexual assault of men: a series. Genitourin Med (1990) 1.77
Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev (1999) 1.72
Lung carcinoma in former smokers. Cancer (1996) 1.70
Chlamydial infection in homosexual men. Frequency of isolation of Chlamydia trachomatis from the urethra, ano-rectum, and pharynx. Br J Vener Dis (1981) 1.67
Novel recombinant-antigen enzyme immunoassay for serological diagnosis of syphilis. J Clin Microbiol (1998) 1.65
The prevalence of rectal chlamydial infection amongst men who have sex with men attending the genitourinary medicine clinic in Edinburgh. Int J STD AIDS (2004) 1.64
Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med (1998) 1.64
Sigmoidoscopic and microscopic appearance of the rectal mucosa in homosexual men. Gut (1981) 1.59
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis (1995) 1.57
Gonorrhea in the homosexual man: frequency of infection by culture site. Sex Transm Dis (1979) 1.55
Evolutionary evidence of the effect of rare variants on disease etiology. Clin Genet (2010) 1.54
Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res (1999) 1.53
Enzyme immunoassay for anti-treponemal IgG: screening or confirmatory test? J Clin Pathol (1992) 1.51
Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev (1995) 1.51
Rectal gonorrhoea and unsafe sex. Lancet (1991) 1.50
Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst (1999) 1.50
Lung cancer mortality among U.S. uranium miners: a reappraisal. J Natl Cancer Inst (1983) 1.48
Correlates of fitness for duty in hazardous materials firefighters. Am J Ind Med (1999) 1.44
Genital infection in male partners of women with chlamydial infection. Int J STD AIDS (2006) 1.44
Reduced DNA repair capacity in lung cancer patients. Cancer Res (1996) 1.44
Hepatitis B testing and vaccination in patients recently diagnosed with HIV infection. Int J STD AIDS (2008) 1.44
Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol (1999) 1.43
Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev (1996) 1.43
Management of intrameatal warts in men. Int J STD AIDS (1990) 1.41
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res (2001) 1.40
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev (1998) 1.39
Excess leukemia and multiple myeloma in a mining county in northeast Texas. Tex Med (1994) 1.39
The outcome of oropharyngeal gonorrhoea treatment with different regimens. Int J STD AIDS (2005) 1.39
An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity (1999) 1.39
Changing trends of gonococcal infection in homosexual men in Edinburgh. Epidemiol Infect (1991) 1.39
Anal cancer, anal squamous intraepithelial lesions and the genitourinary medicine specialist. Int J STD AIDS (2004) 1.38
Second generation heterosexual transmission of HIV-1 infection from women infected in the United Kingdom. Sex Transm Infect (1998) 1.38
A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res (1998) 1.38
Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer (2000) 1.37
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect (1995) 1.37
Review of processing and analysis methods for DNA methylation array data. Br J Cancer (2013) 1.33
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect (2001) 1.33
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer (1997) 1.32
Medicare enrollment in health maintenance organizations. Health Care Financ Rev (1987) 1.32
Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys (1989) 1.30
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol (1999) 1.30
Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res (1998) 1.30
BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol (1995) 1.29
Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect (2000) 1.29
Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 1.28
Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene (2001) 1.28
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis (2000) 1.26
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis (1999) 1.25
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res (1999) 1.25
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis (2000) 1.25
Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res (1995) 1.23
KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer. Lung Cancer (2009) 1.23
Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. Br J Vener Dis (1979) 1.22
An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res (2001) 1.21
Characterizing long-term contaminant mass discharge and the relationship between reductions in discharge and reductions in mass for DNAPL source areas. J Contam Hydrol (2013) 1.21
Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis (2000) 1.21
Generalist genes and the Internet generation: etiology of learning abilities by web testing at age 10. Genes Brain Behav (2007) 1.20
The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs. J Infect Dis (1981) 1.20
Glucocorticoid therapy and risk of bladder cancer. Br J Cancer (2009) 1.19
The development of breast carcinoma in women with thyroid carcinoma. Cancer (2001) 1.17
Clinical value of the Treponema pallidum haemagglutination test. Br J Vener Dis (1975) 1.16
Kalirin inhibition of inducible nitric-oxide synthase. J Biol Chem (1999) 1.16
A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis (1998) 1.15
Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res (1995) 1.14
Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol (1999) 1.14
Evaluating OSHA's ethylene oxide standard: employer exposure-monitoring activities in Massachusetts hospitals from 1985 through 1993. Am J Public Health (1997) 1.14
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer (2011) 1.13
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (1995) 1.13
Racial stereotyping: survey of psychiatrists in the United Kingdom. BMJ (2001) 1.12
Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS (2004) 1.12
The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.12
The molecular epidemiology of human immunodeficiency virus type 1 in six cities in Britain and Ireland. Virology (1997) 1.11
Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med (1997) 1.11
Evaluation of urethral culture for Neisseria gonorrhoeae in the routine investigation of men attending a STD clinic. Br J Vener Dis (1979) 1.11
Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer (2000) 1.11
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect (1998) 1.10
Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res (1990) 1.10
Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Cancer Res (2001) 1.09
Inhalation and dermal exposure among asphalt paving workers. Ann Occup Hyg (2004) 1.09
Serum immunoglobulin response in uncomplicated gonorrhoea. Br J Vener Dis (1979) 1.08
Regulation of endothelial nitric-oxide synthase during hypoxia. J Biol Chem (1996) 1.08
N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer (1999) 1.08